9p21染色体单核苷酸多态性与冠心病相关性的研究进展(5)
| 第1页 |
参见附件。
[27] Gizard F，Nomiyama T，Zhao Y，et al. The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation[J]. Circ Res，2008，103(10)：1155-1163.
[28] Segev A，Nili N，Qiang B，et al. Inhibition of intimal hyperplasia after stenting by over-expression of p15： a member of the INK4 family of cyclin-dependent kinase inhibitors[J]. Mol Cell Cardiol，2011，50(3)：417-425.
[29] Visel A，Zhu Y，May D，et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice[J]. Nature，2010，464(7287)： 409-412.
[30] Holdt LM，Beutner F，Scholz M，et al. Anril expression is associated with atherosclerosis risk at chromosome 9p21[J]. Arterioscler Thromb Vasc Biol，2010，30(3)：620-627.
[31] Musunuru K. Regulatory elements in noncoding dna in the chromosome 9p21 locus[J]. Circ Cardiovasc Genet，2011，4(3)：330-331.
[32] Harismendy O，Notani D，Song X，et al. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signaling response[J]. Nature，2011，470(7333)：264-268.
[33] Cunnington MS，Keavney B. Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus[J]. Curr Atheroscler Rep，2011，13(3)： 193-201.
(收稿日期：2013-11-01)
您现在查看是摘要介绍页，详见PDF附件。